Rania B. Bakr

1.8k total citations · 1 hit paper
54 papers, 1.4k citations indexed

About

Rania B. Bakr is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Rania B. Bakr has authored 54 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Organic Chemistry, 13 papers in Pharmacology and 10 papers in Molecular Biology. Recurrent topics in Rania B. Bakr's work include Synthesis and biological activity (43 papers), Synthesis and Biological Evaluation (14 papers) and Synthesis and Characterization of Heterocyclic Compounds (12 papers). Rania B. Bakr is often cited by papers focused on Synthesis and biological activity (43 papers), Synthesis and Biological Evaluation (14 papers) and Synthesis and Characterization of Heterocyclic Compounds (12 papers). Rania B. Bakr collaborates with scholars based in Egypt, Saudi Arabia and Malaysia. Rania B. Bakr's co-authors include Nadia A. A. Elkanzi, Mohamed A. Abdelgawad, Khaled R.A. Abdellatif, Amany A. Azouz, Hajer Hrichi, Wassila Derafa, Hany A. Omar, Eman K. A. Abdelall, Islam H. El Azab and Wafaa R. Mohamed and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecules and European Journal of Medicinal Chemistry.

In The Last Decade

Rania B. Bakr

52 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synthesis of Chalcones Derivatives and Their Biological Activities: A Review

2022 202 citations Nadia A. A. Elkanzi, Hajer Hrichi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rania B. Bakr Egypt	21	1.1k	331	193	114	88	54	1.4k
Mohamed M. Abdalla Egypt	26	1.5k 1.3×	348 1.1×	227 1.2×	116 1.0×	94 1.1×	89	1.8k
Eman A. Fayed Egypt	27	1.3k 1.1×	485 1.5×	219 1.1×	180 1.6×	104 1.2×	48	1.6k
Ghaneya S. Hassan Egypt	19	956 0.9×	258 0.8×	259 1.3×	97 0.9×	97 1.1×	39	1.2k
Mohammed A. Khedr Egypt	22	781 0.7×	325 1.0×	112 0.6×	91 0.8×	102 1.2×	59	1.1k
Syed Shafi India	17	998 0.9×	482 1.5×	142 0.7×	90 0.8×	98 1.1×	65	1.4k
Mamdouh F. A. Mohamed Egypt	22	950 0.8×	597 1.8×	127 0.7×	117 1.0×	146 1.7×	58	1.4k
Razieh Ghodsi Iran	22	872 0.8×	525 1.6×	266 1.4×	185 1.6×	95 1.1×	62	1.3k
Abdulrahman M. Al‐Obaid Saudi Arabia	18	1.3k 1.1×	559 1.7×	127 0.7×	50 0.4×	92 1.0×	55	1.6k
Syed Nazreen Saudi Arabia	21	758 0.7×	358 1.1×	127 0.7×	93 0.8×	63 0.7×	59	1.1k
Hayam M. A. Ashour Egypt	21	1.3k 1.1×	268 0.8×	170 0.9×	94 0.8×	102 1.2×	31	1.5k

Countries citing papers authored by Rania B. Bakr

Since Specialization

Citations

This map shows the geographic impact of Rania B. Bakr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rania B. Bakr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rania B. Bakr more than expected).

Fields of papers citing papers by Rania B. Bakr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rania B. Bakr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rania B. Bakr. The network helps show where Rania B. Bakr may publish in the future.

Co-authorship network of co-authors of Rania B. Bakr

This figure shows the co-authorship network connecting the top 25 collaborators of Rania B. Bakr. A scholar is included among the top collaborators of Rania B. Bakr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rania B. Bakr. Rania B. Bakr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fadaly, Wael A. A., et al.. (2025). Design, Synthesis and Biological Evaluation of Phenoxyacetic Acid derivatives Linked to Pyrazole Scaffold as PPAR-α/γ Agonists and COX-2 Inhibitors with Dual Antidiabetic/Anti-inflammatory Activities. Journal of Molecular Structure. 1340. 142578–142578. 4 indexed citations

Mohamed, Fatma El Zahraa Ammar, et al.. (2025). Optimization of pyrazole/1,2,4-triazole as dual EGFR/COX-2 inhibitors: Design, synthesis, anticancer potential, apoptosis induction and cell cycle analysis. European Journal of Medicinal Chemistry. 287. 117340–117340. 4 indexed citations

Elkanzi, Nadia A. A., et al.. (2024). Antioxidant and Antimicrobial Potential of 1,8‐Naphthyridine Based Scaffolds: Design, Synthesis and in Silico Simulation Studies within Topoisomerase II. Chemistry & Biodiversity. 21(6). e202301746–e202301746. 4 indexed citations

Ghoneim, Mohammed M., Mohamed A. Abdelgawad, Nadia A. A. Elkanzi, et al.. (2024). A literature review on pharmacological aspects, docking studies, and synthetic approaches of quinazoline and quinazolinone derivatives. Archiv der Pharmazie. 357(8). e2400057–e2400057. 17 indexed citations

Ghoneim, Mohammed M., Mohamed A. Abdelgawad, Nadia A. A. Elkanzi, & Rania B. Bakr. (2024). Review of the recent advances of pyrazole derivatives as selective COX-2 inhibitors for treating inflammation. Molecular Diversity. 29(2). 1789–1820. 5 indexed citations

Bakr, Rania B., Islam H. El Azab, & Nadia A. A. Elkanzi. (2024). Construction and Docking Studies of Novel Pyrimido[4,5‐b]quinolines as Antimicrobial Agents. Chemistry & Biodiversity. 21(6). e202400200–e202400200. 2 indexed citations

Kumar, Sunil, Bishnu Prasad Pandey, Mohamed A. Abdelgawad, et al.. (2024). Inhibition of monoamine oxidases by heterocyclic derived conjugated dienones: synthesis and in vitro and in silico investigations. RSC Medicinal Chemistry. 16(1). 221–231. 2 indexed citations

Abdelgawad, Mohamed A., Syed Nasir Abbas Bukhari, Arafa Musa, et al.. (2023). Phthalazone tethered 1,2,3-triazole conjugates: In silico molecular docking studies, synthesis, in vitro antiproliferative, and kinase inhibitory activities. Bioorganic Chemistry. 133. 106404–106404. 14 indexed citations

Bakr, Rania B. & Nadia A. A. Elkanzi. (2022). Novel 1,2-Thiazine-Pyridine Hybrid: Design, Synthesis, Antioxidant Activity and Molecular Docking Study. Letters in Drug Design & Discovery. 19(8). 675–690. 2 indexed citations

10.

Abdelgawad, Mohamed A., Arafa Musa, Atiah H. Almalki, et al.. (2021). Novel Phenolic Compounds as Potential Dual EGFR and COX-2 Inhibitors: Design, Semisynthesis, in vitro Biological Evaluation and in silico Insights. Drug Design Development and Therapy. Volume 15. 2325–2337. 35 indexed citations

11.

Azab, Islam H. El, Hamdy S. El‐Sheshtawy, Rania B. Bakr, & Nadia A. A. Elkanzi. (2021). New 1,2,3-Triazole-Containing Hybrids as Antitumor Candidates: Design, Click Reaction Synthesis, DFT Calculations, and Molecular Docking Study. Molecules. 26(3). 708–708. 46 indexed citations

12.

Elkanzi, Nadia A. A., et al.. (2020). Synthesis, in vitro evaluation and molecular docking of new pyrazole derivatives bearing 1,5,10,10a-tetrahydrobenzo[g]quinoline-3-carbonitrile moiety as potent antibacterial agents. Journal of the Iranian Chemical Society. 18(4). 977–991. 12 indexed citations

13.

Elkanzi, Nadia A. A., et al.. (2019). Design, Efficient Synthesis and Antimicrobial Evaluation of Some Novel Pyrano[2, 3-b][1, 8]Naphthyridine and Pyrrolo [2,3-f][1,8] Naphth- yridine Derivatives. Der pharma chemica. 11(2). 6–13. 3 indexed citations

14.

Bakr, Rania B., et al.. (2019). Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold. Bioorganic Chemistry. 88. 102964–102964. 30 indexed citations

15.

Abdelgawad, Mohamed A., Rania B. Bakr, & Amany A. Azouz. (2018). Novel pyrimidine-pyridine hybrids: Synthesis, cyclooxygenase inhibition, anti-inflammatory activity and ulcerogenic liability. Bioorganic Chemistry. 77. 339–348. 66 indexed citations

16.

Abdelgawad, Mohamed A., Rania B. Bakr, & Hany A. Omar. (2017). Design, synthesis and biological evaluation of some novel benzothiazole/benzoxazole and/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents. Bioorganic Chemistry. 74. 82–90. 92 indexed citations

17.

Abdelgawad, Mohamed A., et al.. (2016). Design, synthesis and antitumor activity of novel pyrazolo[3,4-d]pyrimidine derivatives as EGFR-TK inhibitors. Bioorganic Chemistry. 66. 88–96. 81 indexed citations

18.

Abdelall, Eman K. A., et al.. (2014). Enhancement to synthesize, design and dock of novel EGFR inhibitors containing pyrazolo[3,4-d]pyrimidine cores of expectedanticancer activity. 10(12). 5 indexed citations

19.

Abdellatif, Khaled R.A., Eman K. A. Abdelall, Mohamed A. Abdelgawad, Rasha R. Ahmed, & Rania B. Bakr. (2014). Synthesis, docking study and antitumor evaluation of certain newly synthesized pyrazolo[3,4-d]pyrimidine derivatives. 10(4). 10 indexed citations

20.

Bakr, Rania B., Eman K. A. Abdelall, Mohamed Abdel‐Hamid, & Manal M. Kandeel. (2012). DESIGN AND SYNTHESIS OF NEW EGFR- TYROSINE KINASE INHIBITORS CONTAINING PYRAZOLO[3,4-d]PYRIMIDINE CORES AS ANTICANCER AGENTS. Bulletin of Pharmaceutical Sciences Assiut. 35(1). 27–42. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact